BioCryst Pharmaceuticals (NASDAQ:BCRX – Get Free Report) was downgraded by analysts at Royal Bank Of Canada from an “outperform” rating to a “sector perform” rating in a research note issued on Thursday, Marketbeat reports. They currently have a $11.00 price target on the biotechnology company’s stock. Royal Bank Of Canada’s price target points to a […]

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) was upgraded by Wall Street Zen to a “hold” rating in a note issued to investors on Saturday, Wall Street Zen reports. A number of other analysts have also recently weighed in on CRNX. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Crinetics Pharmaceuticals in a research […]

Wall Street Zen upgraded shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) from a strong sell rating to a sell rating in a report issued on Saturday,Wall Street Zen reports. Other equities research analysts also recently issued reports about the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Recursion Pharmaceuticals in a […]

Wall Street Zen cut shares of BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) from a strong-buy rating to a buy rating in a report released on Saturday,Wall Street Zen reports. Several other equities research analysts have also recently issued reports on the stock. Needham & Company LLC lowered their target price on shares of BioCryst Pharmaceuticals […]